N-CSRS/A 1 tap-zevenbergen_ncsrsa.htm AMENDED SEMI-ANNUAL CERTIFIED SHAREHOLDER REPORT






UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES



Investment Company Act file number 811-21422



Trust for Advised Portfolios
(Exact name of registrant as specified in charter)



615 East Michigan Street
Milwaukee, Wisconsin 53202
(Address of principal executive offices) (Zip code)



Christopher E. Kashmerick
Trust for Advised Portfolios
777 East Wisconsin Avenue, 10th Floor
Milwaukee, Wisconsin 53202
(Name and address of agent for service)



(626) 914-7385
Registrant's telephone number, including area code



Date of fiscal year end: June 30


Date of reporting period:  December 31, 2020



Item 1. Reports to Stockholders.


 

 

 

ZEVENBERGEN GROWTH FUND

INVESTOR CLASS (ZVNBX)

INSTITUTIONAL CLASS (ZVNIX)

 

ZEVENBERGEN GENEA FUND

INVESTOR CLASS (ZVGNX)

INSTITUTIONAL CLASS (ZVGIX)

 


 

SEMI ANNUAL REPORT TO SHAREHOLDERS

 

DECEMBER 31, 2020

 

Important Notice: In accordance with the U.S. Securities and Exchange Commission, shareholder reports will be available electronically beginning July 1, 2021. Accordingly, paper copies will no longer be mailed. Instead, at that time, the Zevenbergen Growth Fund and the Zevenbergen Genea Fund will send a notice, either by mail or e-mail, each time an updated report is available on the Fund’s website (www.zci.com/funds). Investors enrolled in electronic delivery will receive the notices by e-mail, with links to the updated report and will not need to take any action. Investors who are not enrolled in electronic delivery by July 1, 2021 will receive the notices in the mail.

 

All investors who prefer to receive shareholder reports in a printed format may, at any time, choose that option free of charge. Contact your financial intermediary to make this election, or direct investors can call 1-844-ZVNBRGN.

 

 

 

TABLE OF CONTENTS

 

ZEVENBERGEN GROWTH FUND  
   
Allocation of Portfolio Holdings 1
   
Schedule of Investments 2
   
Statement of Assets and Liabilities 4
   
Statement of Operations 5
   
Statements of Changes in Net Assets 6
   
Financial Highlights 7
   
ZEVENBERGEN GENEA FUND  
   
Allocation of Portfolio Holdings 9
   
Schedule of Investments 10
   
Statement of Assets and Liabilities 12
   
Statement of Operations 13
   
Statements of Changes in Net Assets 14
   
Financial Highlights   15
   
NOTES TO FINANCIAL STATEMENTS 17
   
EXPENSE EXAMPLE 24
   
ADDITIONAL INFORMATION 25
   
PRIVACY NOTICE 28

 

 

Zevenbergen Growth Fund
Allocation of Portfolio Holdings
(Calculated as a percentage of Total Investments)
December 31, 2020 (Unaudited)

 

 

 


* Short-Term Investments consist of amounts held in money market funds. The Fund strategy does not seek to hold large cash balances (more than 5% of total investments), and any significant cash holdings are typically due to trade settlement timing.

 

1 

Zevenbergen Growth Fund
Schedule of Investments
December 31, 2020 (Unaudited)

 

Number of
Shares
        Value  
        COMMON STOCKS ― 98.8%        
        CONSUMER DISCRETIONARY ― 38.8%        
                 
  1,750     Amazon.com, Inc. (a)   $ 5,699,627  
  24,950     Chegg, Inc. (a)     2,253,734  
  28,000     Chewy, Inc. (a)     2,516,920  
  4,300     lululemon athletica inc. (a)     1,496,529  
  3,800     MercadoLibre, Inc. (a)     6,365,836  
  8,000     Netflix, Inc. (a)     4,325,840  
  19,000     Peloton Interactive, Inc. (a)     2,882,680  
  13,100     Tesla, Inc. (a)     9,244,277  
  7,050     The Trade Desk, Inc. (a)     5,647,050  
  67,475     Uber Technologies, Inc. (a)     3,441,225  
              43,873,718  
                 
        CONSUMER STAPLES ― 0.9%        
  8,000     Beyond Meat, Inc. (a)     1,000,000  
                 
        FINANCIALS ― 1.6%        
  9,000     Goosehead Insurance, Inc.     1,122,840  
  5,700     Lemonade, Inc. (a)     698,250  
              1,821,090  
                 
        HEALTH CARE ― 13.9%        
  20,100     Adaptive Biotechnologies Corporation (a)     1,188,513  
  42,400     Exact Sciences Corporation (a)     5,617,576  
  33,350     GoodRx Holdings, Inc. (a)     1,345,339  
  7,000     Seagen Inc. (a)     1,225,980  
  22,275     Teladoc Health, Inc. (a)     4,454,109  
  6,800     Veeva Systems Inc. (a)     1,851,300  
              15,682,817  
                 
        INDUSTRIALS ― 8.1%        
  9,500     Paylocity Holding Corporation (a)     1,956,145  
  12,000     PayPal Holdings, Inc. (a)     2,810,400  
  20,300     Square, Inc. (a)     4,418,092  
              9,184,637  
                 
        REAL ESTATE ― 5.6%        
  1,630     CoStar Group, Inc. (a)     1,506,576  
  37,100     Zillow Group, Inc. Class C (a)     4,815,580  
              6,322,156  

 

The accompanying notes are an integral part of these financial statements.

 

2 

 

Zevenbergen Growth Fund
Schedule of Investments
December 31, 2020 (Unaudited)

 

Number of
Shares
        Value  
        TECHNOLOGY ― 29.9%        
  6,405     Coupa Software Incorporated (a)   $ 2,170,719  
  8,140     NVIDIA Corporation     4,250,708  
  16,925     Okta, Inc. (a)     4,303,350  
  19,000     QUALCOMM Incorporated     2,894,460  
  10,175     RingCentral, Inc. (a)     3,856,020  
  6,100     ServiceNow, Inc. (a)     3,357,623  
  5,725     Shopify Inc. (a)     6,480,414  
  35,000     Snap Inc. (a)     1,752,450  
  1,650     Snowflake Inc. (a)     464,310  
  16,800     Sprout Social, Inc. (a)     762,888  
  13,200     Unity Software Inc. (a)     2,025,804  
  4,485     Zoom Video Communications, Inc. (a)     1,512,880  
              33,831,626  
                 
        TOTAL COMMON STOCKS
(Cost $59,290,789)
  $ 111,716,044  
                 
        MONEY MARKET FUNDS ― 0.8%        
  972,040     First American U.S. Treasury Money Market Fund, Class Z, 0.01% (b)     972,040  
        TOTAL SHORT-TERM INVESTMENTS (Cost $972,040)   $ 972,040  
                 
        TOTAL INVESTMENTS ― 99.6% (Cost $60,262,829)     112,688,084  
        Other Assets in Excess of Liabilities ― 0.4%     441,301  
        TOTAL NET ASSETS ― 100.0%   $ 113,129,385  

 

(a): Non Income Producing.

 

(b): Variable rate security. The rate disclosed is the annualized seven-day effective yield as of December 31, 2020.

 

3 

 

Zevenbergen Growth Fund
Statement of Assets and Liabilities
December 31, 2020 (Unaudited)

 

Assets      
Investments in securities, at value (cost $60,262,829)   $ 112,688,084  
Dividend and interest receivable     8  
Receivable for Fund shares sold     1,491,744  
Prepaid expenses     26,281  
Total Assets     114,206,117  
         
Liabilities        
Payable for Fund shares redeemed     364,445  
Payable for securities purchased     513,420  
Payable to Adviser     141,047  
Distribution fees - Investor Class     16,420  
Accrued other expenses and other liabilities     41,400  
Total Liabilities     1,076,732  
         
Net Assets   $ 113,129,385  
         
Components of Net Assets        
Paid-in capital   $ 60,563,557  
Total distributable earnings     52,565,828  
Net Assets   $ 113,129,385  
         
Investor Class:        
Net assets   $ 43,437,235  
Shares outstanding (unlimited number of shares authorized, no par value)     1,016,978  
Net asset value, offering and redemption price per share *   $ 42.71  
         
Institutional Class:        
Net assets   $ 69,692,150  
Shares outstanding (unlimited number of shares authorized, no par value)     1,609,623  
Net asset value, offering and redemption price per share *   $ 43.30  

 


* Shares redeemed or exchanged within 90 days of purchase are charged a 1.00% redemption fee (Note 9).

 

The accompanying notes are an integral part of these financial statements.

 

4 

Zevenbergen Growth Fund
Statement of Operations
For the Six Months Ended December 31, 2020 (Unaudited)

 

Investment Income      
Dividends and interest income   $ 35,943  
         
Expenses        
Advisory fees     329,183  
Administration fees (Note 3)     49,422  
Shareholder servicing fees     48,856  
Distribution fees - Investor Class     38,539  
Transfer agent fees and expenses (Note 3)     21,160  
Registration fees     20,782  
Legal fees     10,844  
Audit fees     7,912  
Custody fees (Note 3)     7,626  
Compliance fees (Note 3)     6,624  
Trustees' fees     5,888  
Shareholder reporting fees     2,128  
Insurance fees     1,409  
Miscellaneous expenses     954  
Total expenses     551,327  
Expenses waived and reimbursed by the Adviser (Note 3)     (93,602 )
Net Expenses     457,725  
         
Net Investment Loss     (421,782 )
         
Realized and Unrealized Gain on Investments        
Net realized gain on investments     1,343,231  
Change in unrealized appreciation on investments     29,649,248  
Net Realized and Unrealized Gain on Investments     30,992,479  
         
Net Increase in Net Assets from Operations   $ 30,570,697  

 

The accompanying notes are an integral part of these financial statements.

 

5 

 

Zevenbergen Growth Fund
Statements of Changes in Net Assets


Operations   For the Six Months
Ended
December 31, 2020 (Unaudited)
    For the Year
Ended
June 30, 2020
 
Net investment loss   $ (421,782 )   $ (272,739 )
Net realized gain (loss) on investments     1,343,231       (499,239 )
Net change in unrealized appreciation on investments     29,649,248       15,723,445  
Net Increase in Net Assets from Operations     30,570,697       14,951,467  
                 
Distributions to shareholders from                
Net realized loss on investments                
Investor Class     (28,530 )      
Institutional Class     (44,888 )      
Total distributions to shareholders     (73,418 )      
                 
                 
Capital Transactions                
Proceeds from shares sold                
Investor Class     23,321,406       13,574,932  
Institutional Class     26,892,096       15,697,643  
Proceeds from shares reinvested                
Investor Class     28,457        
Institutional Class     44,273        
Cost of shares redeemed                
Investor Class     (9,791,865 )     (3,969,298 )
Institutional Class     (13,700,105 )     (3,633,206 )
Redemption fees                
Investor Class     16,868       7,748  
Institutional Class     27,952       17,169  
Net Increase in Net Assets from Capital Share Transactions     26,839,082       21,694,988  
Total Increase in Net Assets     57,336,361       36,646,455  
                 
Net Assets                
Beginning of year     55,793,024       19,146,569  
End of year   $ 113,129,385     $ 55,793,024  
                 
Capital Shares Transactions                
Investor Class                
Shares sold     650,184       601,012  
Shares reinvested     631          
Shares redeemed     (270,378 )     (199,182 )
Net increase in shares outstanding     380,437       401,830  
                 
Institutional Class                
Shares sold     744,216       672,998  
Shares reinvested     968          
Shares redeemed     (404,110 )     (169,981 )
Net increase in shares outstanding     341,074       503,017  

 

The accompanying notes are an integral part of these financial statements.

 

6 

 

Zevenbergen Growth Fund
Financial Highlights

Investor Class

 

For a Capital Share Outstanding Throughout Each Period Presented:
    For the Six Months
Ended
December 31, 2020
(Unaudited)
    For the Year
Ended
June 30, 2020
    For the Year
Ended
June 30, 2019
    For the Year
Ended
June 30, 2018
    For the Year
Ended
June 30, 2017
 
Net Asset Value, Beginning of Period   $ 29.05     $ 19.00     $ 16.33     $ 12.27     $ 9.05  
                                         
Gain (Loss) from Investment Operations:                                        
Net investment loss (1)     (0.01 )     (0.27 )     (0.20 )     (0.17 )     (0.13 )
Net realized and unrealized gain on investments     13.70       10.30       2.85       4.22       3.35  
Total Gain from Investment Operations     13.69       10.03       2.65       4.05       3.22  
                                         
Less Distributions from Net Realized Gain:     (0.03 )                        
                                         
Redemption Fee Proceeds (1)     *     0.02       0.02       0.01        
                                         
Net Asset Value, End of Period   $ 42.71     $ 29.05     $ 19.00     $ 16.33     $ 12.27  
                                         
Total Return     47.02 %(2)     52.89 %     16.35 %     33.09 %     35.58 %
                                         
Supplemental Data and Ratios:                                        
Net assets, end of period (in thousands)   $ 43,437     $ 18,492     $ 4,460     $ 1,292     $ 194  
Ratio of expenses to average net assets                                        
Before fees waived and reimbursed by the Adviser     1.52
%(3)
    2.14 %     2.78 %     3.63 %     5.89 %
After fees waived and reimbursed by the Adviser     1.30
%(3)
    1.30 %     1.30 %     1.30 %     1.30 %
Ratio of net investment loss to average net assets                                        
Before fees waived and reimbursed by the Adviser     -1.44
%(3)
    -2.12 %     -2.69 %     -3.53 %     -5.76 %
After fees waived and reimbursed by the Adviser     -1.21 %(3)     -1.28 %     -1.21 %     -1.20 %     -1.17 %
Portfolio turnover rate (4)     21.21 %(2)
    38.74 %     28.68 %     31.12 %     25.90 %
                                         

 


* Less than $0.01 per share

(1) Per share amounts have been calculated using the average shares method

(2) Not annualized

(3) Annualized

(4) Portfolio turnover rate is calculated for the Fund without distinguishing between classes.

 

The accompanying notes are an integral part of these financial statements.

 

7 

Zevenbergen Growth Fund
Financial Highlights
Institutional Class

 

For a Capital Share Outstanding Throughout Each Period Presented:

 

    For the Six Months
Ended
December 31, 2020
(Unaudited)
    For the Year
Ended
June 30, 2020
    For the Year
Ended
June 30, 2019
    For the Year
Ended
June 30, 2018
    For the Year
Ended
June 30, 2017
 
Net Asset Value, Beginning of Period   $ 29.40     $ 19.18     $ 16.45     $ 12.33     $ 9.07  
                                         
Gain (Loss) from Investment Operations:                                        
Net investment loss (1)           (0.20 )     (0.15 )     (0.13 )     (0.09 )
Net realized and unrealized gain on investments     13.93       10.40       2.87       4.24       3.35  
Total Gain from Investment Operations     13.93       10.20       2.72       4.11       3.26  
                                         
Less Distributions from Net Realized Gain:     (0.03 )                        
                                         
Redemption Fee Proceeds (1)     *     0.02       0.01       0.01       *
                                         
Net Asset Value, End of Period   $ 43.30     $ 29.40     $ 19.18     $ 16.45     $ 12.33  
                                         
Total Return     47.28 %(2)     53.28 %     16.60 %     33.41 %     35.94 %
                                         
Supplemental Data and Ratios:                                        
Net assets, end of period (in thousands)   $ 69,692     $ 37,302     $ 14,686     $ 10,970     $ 6,427  
Ratio of expenses to average net assets                                        
Before fees waived and reimbursed by the Adviser     1.23 %(3)     1.90 %     2.52 %     3.55 %     5.86 %
After fees waived and reimbursed by the Adviser     1.00 %(3)     1.00 %     1.00 %     1.00 %     1.00 %
Ratio of net investment loss to average net assets                                        
Before fees waived and reimbursed by the Adviser     -1.14 %(3)     -1.88 %     -2.43 %     -3.45 %     -5.72 %
After fees waived and reimbursed by the Adviser     -0.91 %(3)     -0.98 %     -0.91 %     -0.90 %     -0.87 %
Portfolio turnover rate (4)     21.21 %(2)     38.74 %     28.68 %     31.12 %     25.90 %

 


* Less than $0.01 per share

(1) Per share amounts have been calculated using the average shares method

(2) Not annualized

(3) Annualized

(4) Portfolio turnover rate is calculated for the Fund without distinguishing between classes.

 

The accompanying notes are an integral part of these financial statements.

 

8 

 

Zevenbergen Genea Fund
Allocation of Portfolio Holdings
(Calculated as a percentage of Total Investments)
December 31, 2020 (Unaudited)

 

 


* Short-Term Investments consist of amounts held in money market funds. The Fund strategy does not seek to hold large cash balances (more than 5% of total investments), and any significant cash holdings are typically due to trade settlement timing.

 

9 

 

Zevenbergen Genea Fund

Schedule of Investments

December 31, 2020 (Unaudited)

 

Number of            
Shares         Value  
        COMMON STOCKS ― 97.4%        
        CONSUMER DISCRETIONARY ― 41.6%        
  2,640     Amazon.com, Inc. (a)   $ 8,598,295  
  42,550     Chegg, Inc. (a)     3,843,542  
  42,500     Chewy, Inc. (a)     3,820,325  
  20,085     Etsy, Inc. (a)     3,573,323  
  5,180     MercadoLibre, Inc. (a)     8,677,640  
  10,610     Netflix, Inc. (a)     5,737,145  
  44,860     Peloton Interactive, Inc. (a)     6,806,159  
  19,775     Tesla, Inc. (a)     13,954,624  
  10,290     The Trade Desk, Inc. (a)     8,242,290  
  104,800     Uber Technologies, Inc. (a)     5,344,800  
              68,598,143  
        CONSUMER STAPLES ― 1.2%        
  15,300     Beyond Meat, Inc. (a)     1,912,500  
        FINANCIALS ― 2.7%        
  36,815     Lemonade, Inc. (a)     4,509,838  
        HEALTH CARE ― 0.9%        
  38,345     GoodRx Holdings, Inc. (a)     1,546,837  
        INDUSTRIALS ― 8.7%        
  20,650     Axon Enterprise, Inc. (a)     2,530,244  
  21,100     Bill.com Holdings, Inc. (a)     2,880,150  
  36,500     Square, Inc. (a)     7,943,860  
  37,868     Virgin Galactic Holdings, Inc. (a)     898,608  
              14,252,862  
        REAL ESTATE ― 4.9%        
  62,315     Zillow Group, Inc. Class C (a)     8,088,487  
        TECHNOLOGY ― 37.4%        
  10,400     Coupa Software Incorporated (a)     3,524,664  
  29,300     Datadog, Inc. (a)     2,884,292  
  12,140     MongoDB, Inc. (a)     4,358,746  
  11,865     NVIDIA Corporation     6,195,903  
  21,375     Okta, Inc. (a)     5,434,807  
  84,030     Pinterest, Inc. (a)     5,537,577  
  6,050     ServiceNow, Inc. (a)     3,330,102  
  7,515     Shopify Inc. (a)     8,506,604  

 

The accompanying notes are an integral part of these financial statements.

 

10 

 

Zevenbergen Genea Fund

Schedule of Investments

December 31, 2020 (Unaudited)

 

Number of

Shares

        Value  
        TECHNOLOGY ― 37.4% (Continued)        
  64,500     Snap Inc. (a)   $ 3,229,515  
  12,100     Snowflake Inc. (a)     3,404,940  
  37,540     Sprout Social, Inc. (a)     1,704,691  
  15,550     Twilio Inc. (a)     5,263,675  
  25,400     Unity Software Inc. (a)     3,898,138  
  12,850     Zoom Video Communications, Inc. (a)     4,334,562  
              61,608,216  
        TOTAL COMMON STOCKS        
        (Cost $86,572,556)   $ 160,516,883  
                 
        SHORT-TERM INVESTMENTS ― 1.2%        
  2,046,095     First American U.S. Treasury Money Market Fund, Class Z, 0.01% (b)     2,046,095  
        TOTAL SHORT-TERM INVESTMENTS (Cost $2,046,095)   $ 2,046,095  
                 
        TOTAL INVESTMENTS ― 98.6% (Cost $88,618,651)     162,562,978  
        Other Assets in Excess of Liabilities ― 1.4%     2,373,139  
        TOTAL NET ASSETS ― 100.0%   $ 164,936,117  

 


(a): Non Income Producing.

 


(b): Variable rate security. The rate disclosed is the annualized seven-day effective yield as of December 31, 2020.

 

The accompanying notes are an integral part of these financial

 

11 

 

Zevenbergen Genea Fund
Statement of Assets and Liabilities
December 31, 2020 (Unaudited)

 

Assets      
Investments in securities, at value (cost $88,618,651)   $ 162,562,978  
Receivable for Fund shares sold     2,832,120  
Interest receivable     17  
Prepaid expenses     28,753  
Total Assets     165,423,868  
         
Liabilities        
Payable for Fund shares redeemed     164,876  
Payable to Adviser     242,832  
Distribution fees - Investor Class     24,013  
Accrued other expenses and other liabilities     56,030  
Total Liabilities     487,751  
         
Net Assets   $ 164,936,117  
         
Components of Net Assets        
Paid-in capital   $ 94,164,454  
Total distributable earnings     70,771,663  
Net Assets   $ 164,936,117  
         
Investor Class:        
Net assets   $ 98,712,828  
Shares outstanding (unlimited number of shares authorized, no par value)     1,817,008  
Net asset value, offering and redemption price per share *   $ 54.33  
         
Institutional Class:        
Net assets   $ 66,223,289  
Shares outstanding (unlimited number of shares authorized, no par value)     1,202,884  
Net asset value, offering and redemption price per share *   $ 55.05  

 

* Shares redeemed or exchanged within 90 days of purchase are charged a 1.00% redemption fee (Note 9).

 

The accompanying notes are an integral part of these financial statements.

 

12 

 

Zevenbergen Genea Fund
Statement of Operations
For the Six Months Ended December 31, 2020 (Unaudited)

 

Investment Income      
Dividends and interest income   $ 3,445  
         
Expenses        
Advisory fees     441,530  
Distribution fees - Investor Class     71,149  
Shareholder servicing fees     63,289  
Administration fees (Note 3)     47,146  
Transfer agent fees and expenses (Note 3)     22,044  
Registration fees     17,713  
Legal fees     11,914  
Audit fees     7,912  
Compliance fees (Note 3)     6,072  
Trustees' fees     5,888  
Shareholder reporting fees     4,600  
Miscellaneous expenses     3,864  
Custody fees (Note 3)     3,624  
Insurance fees     1,472  
Total expenses     708,217  
Expenses waived by the Adviser (Note 3)     (83,190 )
Net Expenses     625,027  
         
Net Investment Loss     (621,582 )
         
Realized and Unrealized Gain on Investments        
Net realized gain on investments     1,233,689  
Change in unrealized appreciation on investments     45,340,706  
Net Realized and Unrealized Gain on Investments     46,574,395  
         
Net Increase in Net Assets from Operations   $ 45,952,813  

 

The accompanying notes are an integral part of these financial statements.

 

13 

 

Zevenbergen Genea Fund
Statements of Changes in Net Assets

 

Operations   For the Six Months
Ended
December 31, 2020 (Unaudited)
    For the Year
Ended
June 30, 2020
 
Net investment loss   $ (621,582 )   $ (503,696 )
Net realized gain (loss) on investments     1,233,689       (2,559,382 )
Net change in unrealized appreciation on investments     45,340,706       17,999,600  
Net Increase in Net Assets from Operations     45,952,813       14,936,522  
                 
Capital Transactions                
Proceeds from shares sold                
Investor Class     54,464,049       13,742,698  
Institutional Class     27,862,666       6,071,493  
Cost of shares redeemed                
Investor Class     (15,190,154 )     (17,810,000 )
Institutional Class     (6,173,792 )     (4,320,587 )
Redemption fees                
Investor Class     45,927       12,696  
Institutional Class     32,945       10,340  
Net Increase/(Decrease) in Net Assets from Capital Share Transactions     61,041,641       (2,293,360 )
                 
Total Increase in Net Assets     106,994,454       12,643,162  
                 
Net Assets                
Beginning of year     57,941,663       45,298,501  
End of year   $ 164,936,117     $ 57,941,663  
                 
Capital Shares Transactions                
Investor Class                
Shares sold     1,174,119       544,623  
Shares reinvested            
Shares redeemed     (339,760 )     (815,815 )
Net increase in shares outstanding     834,359       645,716  
                 
Institutional Class                
Shares sold     590,649       248,310  
Shares reinvested            
Shares redeemed     (134,075 )     (201,126 )
Net increase in shares outstanding     456,574       265,641  

 

The accompanying notes are an integral part of these financial statements.

 

14 

 

Zevenbergen Genea Fund
Financial Highlights
Investor Class

 

For a Capital Share Outstanding Throughout Each Period Presented:
    For the Six Months Ended December 31, 2020 (Unaudited)     For the Year Ended June 30, 2020     For the Year Ended June 30, 2019     For the Year Ended June 30, 2018     For the Year Ended June 30, 2017  
Net Asset Value, Beginning of Period   $ 33.34     $ 23.12     $ 20.77     $ 14.20     $ 9.40  
                                         
Gain (Loss) from Investment Operations:                                        
Net investment loss (1)     (0.01 )     (0.32 )     (0.29 )     (0.23 )     (0.16 )
Net realized and unrealized gain on investments     21.00       10.53       2.68       6.79       4.96  
Total Gain from Investment Operations     20.99       10.21       2.39       6.56       4.80  
                                         
Less Distributions from Net Realized Gain:                 (0.06 )            
                                         
Redemption Fee Proceeds (1)     *     0.01       0.02       0.01       *
                                         
Net Asset Value, End of Period   $ 54.33     $ 33.34     $ 23.12     $ 20.77     $ 14.20  
                                         
Total Return     62.96 %(2)     44.20 %     11.72 %     46.27 %     51.06 %
                                         
Supplemental Data and Ratios:                                        
Net assets, end of period (in thousands)   $ 98,713     $ 32,763     $ 28,986     $ 12,633     $ 2,074  
Ratio of expenses to average net assets                                        
Before fees waived and reimbursed by the Adviser     1.57 %(3)     1.98 %     2.09 %     3.35 %     7.96 %
After fees waived and reimbursed by the Adviser     1.40 %(3)     1.40 %     1.40 %     1.40 %     1.40 %
Ratio of net investment loss to average net assets                                        
Before fees waived and reimbursed by the Adviser     -1.56 %(3)     -1.96 %     -2.04 %     -3.27 %     -7.89 %
After fees waived and reimbursed by the Adviser     -1.39 %(3)     -1.38 %     -1.35 %     -1.32 %     -1.33 %
Portfolio turnover rate (4)     7.26 %(2)     61.63 %     35.25 %     22.35 %     67.59 %

 


* Less than $0.01 per share

(1) Per share amounts have been calculated using the average shares method

(2) Not annualized

(3) Annualized

(4) Portfolio turnover rate is calculated for the Fund without distinguishing between classes.

 

The accompanying notes are an integral part of these financial statements.

 

15 

 

Zevenbergen Genea Fund
Financial Highlights
Institutional Class

 

For a Capital Share Outstanding Throughout Each Period Presented:
    For the Six Months Ended December 31, 2020 (Unaudited)     For the Year Ended June 30, 2020     For the Year Ended June 30, 2019     For the Year Ended June 30, 2018     For the Year Ended June 30, 2017  
Net Asset Value, Beginning of Period   $ 33.74     $ 23.33     $ 20.93     $ 14.30     $ 9.41  
                                         
Gain (Loss) from Investment Operations:                                        
Net investment loss (1)     (0.01 )     (0.25 )     (0.22 )     (0.18 )     (0.12 )
Net realized and unrealized gain on investments     21.32       10.65       2.66       6.80       4.99  
Total Gain from Investment Operations     21.31       10.40       2.44       6.62       4.87  
                                         
Less Distributions from Net Realized Gain:                 (0.06 )            
                                         
Redemption Fee Proceeds (1)     *     0.01       0.02       0.01       0.02  
                                         
Net Asset Value, End of Period   $ 55.05     $ 33.74     $ 23.33     $ 20.93     $ 14.30  
                                         
Total Return     63.16 %(2)     44.62 %     11.87 %     46.36 %     51.97 %
                                         
Supplemental Data and Ratios:                                        
Net assets, end of period (in thousands)   $ 66,223     $ 25,179     $ 16,312     $ 9,073     $ 3,669  
Ratio of expenses to average net assets                                        
Before fees waived and reimbursed by the Adviser     1.27 %(3)     1.70 %     1.80 %     3.21 %     8.08 %
After fees waived and reimbursed by the Adviser     1.10 %(3)     1.10 %     1.10 %     1.10 %     1.10 %
Ratio of net investment loss to average net assets                                        
Before fees waived and reimbursed by the Adviser     -1.26 %(3)     -1.68 %     -1.75 %     -3.14 %     -8.02 %
After fees waived and reimbursed by the Adviser     -1.09 %(3)     -1.08 %     -1.05 %     -1.03 %     -1.04 %
Portfolio turnover rate (4)     7.26 %(2)     61.63 %     35.25 %     22.35 %     67.59 %

 


* Less than $0.01 per share

(1) Per share amounts have been calculated using the average shares method

(2) Not annualized

(3) Annualized

(4) Portfolio turnover rate is calculated for the Fund without distinguishing between classes.

 

The accompanying notes are an integral part of these financial statements.

 

16 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)
 

 

NOTE 1 – ORGANIZATION

 

Zevenbergen Growth Fund (the “Growth Fund”) and Zevenbergen Genea Fund (the “Genea Fund”; each a “Fund” collectively the “Funds”) are non-diversified series of Trust for Advised Portfolios (the “Trust”). The Trust, a Delaware Statutory Trust, is registered under the Investment Company Act of 1940, as amended (the “1940 Act”) as an open-end management investment company. Zevenbergen Capital Investments LLC (the “Adviser”) serves as the investment manager to the Funds. The inception date of the Funds was August 31, 2015. The Funds’ investment objective is long-term capital appreciation.

 

Growth Fund and Genea Fund, each, currently offer two classes of shares, Institutional Class and Investor Class. Each share class represents an equal interest in the Fund, except the difference of class specific expenses, which reflects the difference in the range of services provided to each class. Income, expenses (other than class specific), and realized and unrealized gains and losses on investments are allocated daily to each class based on relative net assets.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

The following is a summary of significant accounting policies consistently followed by the Funds in preparation of their financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for investment companies. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board Accounting Standards Codification Topic 946. The presentation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the period. Actual results may differ from those estimates.

 

A. Securities Valuation

 

The Funds follow a fair value hierarchy that distinguishes between market data obtained from independent sources (observable inputs) and the Funds’ own market assumptions (unobservable inputs). The inputs or methodology used in determining the value of each Fund’s investments are not necessarily an indication of the risk associated with investing in those securities.

 

Various inputs are used in determining the value of the Funds’ investments. These inputs are summarized into three broad categories as defined below:

 


Level 1 - Quoted prices in active markets for identical securities. An active market for a security is a market in which transactions occur with sufficient frequency and volume to provide pricing information on an ongoing basis. A quoted price in an active market provides the most reliable evidence of fair value.

 


Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates, and similar data.

 


Level 3 - Significant unobservable inputs, including the Funds’ own assumptions in determining fair value of investments.

 

Equity securities that are traded on a national securities exchange are stated at the last reported sales price on the day of valuation. To the extent these securities are actively traded and valuation adjustments are not applied, they are categorized as Level 1 of the fair value hierarchy.

 

Short-term investments classified as money market instruments are valued at NAV. These investments are categorized as Level 1 of the fair value hierarchy.

 

17 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the fair values of the Funds’ investments in each category investment type as of December 31, 2020:

 

Growth Fund
 
Description     Level 1       Level 2       Level 3       Total  
Assets                                
Common Stocks   $ 111,716,044     $     $     $ 111,716,044  
Short-Term Investments     972,040                   972,040  
Total Assets   $ 112,688,084     $     $     $ 112,688,084  

 

Growth Fund
 
Description     Level 1       Level 2       Level 3       Total  
Assets                                
Common Stocks   $ 160,516,883     $     $     $ 160,516,883  
Short-Term Investments     2,046,095                   2,046,095  
Total Assets   $ 162,562,978     $     $     $ 162,562,978  

 

Please refer to the Schedule of Investments for further classification.

 

B. Security Transactions, Investment Income and Distributions

 

The Funds record security transactions based on trade date. Realized gains and losses on sales of securities are calculated by comparing the original cost of the specifically identified security lot sold with the net sales proceeds. Dividend income is recognized on the ex-dividend date, and interest income is recognized on an accrual basis. Withholding taxes on foreign dividends have been provided for in accordance with the Trust’s understanding of the applicable country’s tax rules and rates.

 

C. Federal Income Taxes

 

The Funds have elected to be taxed as Regulated Investment Companies (“RIC”) under the U.S. Internal Revenue Code of 1986, as amended, and intend to maintain this qualification and to distribute substantially all of their net taxable income to their shareholders. Therefore no provision is made for federal income taxes. Due to the timing of dividend distributions (if any) and the differences in accounting for income and realized gains and losses for financial statement and federal income tax purposes, the fiscal year in which amounts are distributed may differ from the year in which the income and realized gains and losses are recorded by the Funds.

 

Management of the Funds is required to analyze all open tax years, as defined by IRS statute of limitations for all major jurisdictions, including federal tax authorities and certain state tax authorities. As of and during the period ended December 31, 2020, the Funds did not have a liability for any unrecognized tax benefits. Generally, tax authorities can examine tax returns filed for the preceding three years. As of December 31, 2020, the tax years ended June 30, 2020, June 30, 2019, and June 30, 2018, are open to examination. The Funds are not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months.

 

18 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)
 

 

NOTE 3 – INVESTMENT MANAGEMENT AGREEMENT AND OTHER RELATED PARTY TRANSACTIONS

 

The Trust entered into an agreement for the Adviser to furnish investment advisory services to the Funds. Under the terms of this agreement, Growth Fund and Genea Fund will pay the Adviser a monthly fee based on each Fund’s average daily net assets at the annual rate of 0.80% and 0.90%, respectively.

 

The Adviser has contractually agreed to waive its management fee and/or reimburse each Fund’s operating expenses (excluding shareholder servicing fees, any front-end or contingent deferred loads, taxes, leverage interest, brokerage commissions, acquired fund fees and expenses, merger or reorganization-related expenses, portfolio transaction expenses, interest expense and dividends paid on short sales, and extraordinary expenses) to ensure they do not exceed, on an annual basis, the expense limitations, expressed as a percentage rate of the average daily net assets of each Fund, listed below. Waivers or reimbursements are calculated daily and settled monthly or quarterly in conjunction with each Fund's payment of advisory fees.

 

Fund Investor Class Institutional Class
Growth Fund 1.15% 0.90%
Genea Fund 1.25% 1.00%

 

See Note 6 – Shareholder Servicing Plan for shareholder servicing fees charged in addition to fees outlined in this table.

 

The Adviser is permitted to recapture amounts waived and/or reimbursed to a class within three years if the class’s total annual operating expenses have fallen to a level below the expense limitation (“expense cap”) in effect at the time the fees were earned or the expenses incurred, however, in no case will the Adviser recapture any amount that would result, on any particular business day of the Funds, in the class’s total annual operating expenses exceeding the expense cap or any other lower limit then in effect.

 

At December 31, 2020, the expenses reimbursed and contractual fees waived by the Adviser and subject to potential recapture by period were as follows:

 

Fiscal Year waived/reimbursed   Growth Fund   Genea Fund     Expiration  
FYE June 30, 2018   $ 107,238   $ 107,463     June 30, 2021  
FYE June 30, 2019     227,826     224,757     June 30, 2022  
FYE June 30, 2020     230,107     236,776     June 30, 2023  
FYE June 30, 2021     93,602     83,190     December 31, 2023  
    $ 658,773   $ 652,186        

 

U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), serves as the Funds’ administrator and fund accountant and transfer agent. The officers of the Trust are employees of Fund Services. U.S. Bank serves as the Funds’ custodian and provides compliance services to the Funds. Quasar Distributors, LLC (“Quasar” or the “Distributor”), an affiliate of Fund Services until March 31, 2020, acts as the Funds’ distributor and principal underwriter. For the six months ended December 31, 2020, the Funds incurred the following expenses for administration and fund accounting, custody, transfer agent and compliance fees:

 

      Growth Fund     Genea Fund  
Administration   $ 49,422   $ 47,146  
Custody     7,626     3,624  
Transfer Agency     21,160     22,044  
Chief Compliance Officer     6,624     6,072  

 

19 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)
 

 

At December 31, 2020, the Funds had payables due to Fund Services and its affiliates for administration and fund accounting, custody, transfer agent and compliance fees in the following amounts:

 

    Growth Fund     Genea Fund  
Administration   $ 12,815     $ 12,110  
Custody     1,639       2,331  
Transfer Agency     3,193       4,887  
Chief Compliance Officer     2,493       2,952  

 

The above payable amounts are included in the Accrued other expenses and other liabilities line item in the Statement of Assets and Liabilities.

 

The Independent Trustees were paid $11,776 for their services to the Funds during the six months ended December 31, 2020. No compensation is paid directly by the Funds to the Interested Trustee or officers of the Trust.

 

NOTE 4 – INVESTMENT TRANSACTIONS

 

Purchases and sales of investment securities (excluding short-term investments) for each Fund for the six months ended December 31, 2020, were as follows:

 

Growth Fund        
Purchases     $ 42,379,419  
Sales     $ 17,299,901  
Genea Fund          
Purchases     $ 63,628,128  
Sales     $ 7,093,666  

 

NOTE 5 – FEDERAL INCOME TAX INFORMATION

 

At June 30, 2020, the components of distributable earnings for income tax purposes were as follows:

 

    Growth     Genea  
    Fund     Fund  
             
Cost of investments   $ 33,129,054     $ 29,897,596  
Gross unrealized appreciation     23,113,394       28,956,567  
Gross unrealized depreciation     (357,006 )     (673,955 )
Net unrealized appreciation on investments     22,756,388       28,282,612  
                 
Undistributed ordinary income            
Undistributed long-term capital gains            
Accumulated earnings            
                 
Capital loss carryforwards     (523,514 )     (3,331,481 )
Other book/tax temporary differences     (164,325 )     (132,281 )
Total distributable earnings   $ 22,068,549     $ 24,818,850  

 

The difference between book basis and tax basis unrealized appreciation/(depreciation) is attributable in part to the tax deferral of losses on wash sales.

 

20 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)
 

 

GAAP requires that certain components of net assets be reclassified between financial and tax reporting. These reclassifications have no effect on net assets or net asset value per share. For the year ended June 30, 2020, permanent differences, due to net operating losses, in book and tax accounting have been reclassified to capital and distributable earnings as follows:

 

      Distributable Earnings     Paid In Capital  
Growth Fund     $ 189,971     $ (189,971 )
Genea Fund     $ 608,595     $ (608,595 )
                   

 

The following table summarizes the characteristics of distributions paid during the six months ended December 31, 2020:

 

      Short-Term     Long-Term     Total  
 
    Capital Gains     Capital Gains     Distributions Paid  
Growth Fund
  $   $ 73,415   $  
Genea Fund
      $   $  

 

No distributions were paid by the Growth Fund or Genea Fund during the year ended June 30, 2020.

 

The Funds are required, in order to meet certain excise tax requirements, to measure and distribute annually, net capital gains realized during the twelve month period ending October 31. In connection with this requirement, the Funds are permitted, for tax purposes, to defer into their next fiscal year any net capital losses incurred from November 1 through the end of the fiscal year. Late year losses incurred after December 31 within the fiscal year are deemed to arise on the first business day of the following fiscal year for tax purposes. At June 30, 2020, the Funds deferred the following, on a tax basis, losses:

 

      Late Year Loss     Post October Loss  
Growth Fund     $ (164,325 )   $  
Genea Fund     $ (132,281 )   $  

 

At June 30, 2020, the Funds had capital loss carryforwards, which reduce the Funds’ taxable income arising from future net realized gains on investments, if any, to the extent permitted by the Internal Revenue Code, and thus will reduce the amount of distributions to shareholders which would otherwise be necessary to relieve the Funds of any liability for federal tax. Pursuant to the Internal Revenue Code, the character of such capital loss carryforwards is as follows:

 

      Capital Loss Carryforwards Not Subject to Expiration  
      Short-Term     Long-Term     Total  
Growth Fund
    $ (523,514 )   $     $ (523,514 )
Genea Fund
    $ (3,331,481 )   $     $ (3,331,481 )

 

21 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)
 

 

NOTE 6 – SHAREHOLDER SERVICING PLAN

 

The Trust, on behalf of the Funds, has adopted a Shareholder Servicing Plan to pay a fee at an annual rate on average daily net assets as follows:

 

Fund Investor Class Institutional Class
Growth Fund 0.15% 0.10%
Genea Fund 0.15% 0.10%

 

The Shareholder Servicing Plan authorizes payment of a shareholder servicing fee to the financial intermediaries and other service providers who provide administrative and support services to Fund shareholders.

 

For the six months ended December 31, 2020, class specific Shareholder Servicing fees were as follows:

 

Fund   Investor Class     Institutional Class  
Growth Fund   $ 23,123     $ 25,733  
Genea Fund     42,690       27,284  

 

NOTE 7 – DISTRIBUTION PLAN

 

The Trust, on behalf of the Funds, has adopted a Distribution Plan (the “Plan”) pursuant to Rule 12b-1 under the 1940 Act that allows each Fund to pay distribution fees for the sale and distribution of its Investor Class shares. The Plan provides for the payment of distribution fees at the annual rate of up to 0.25% of average daily net assets of the Investor Class shares. For the six months ended December 31, 2020, distribution fees incurred are disclosed on the Statement of Operations.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

In the normal course of business, each Fund enters into contracts that provide general indemnifications by each Fund to the counterparty to the contract. Each Fund’s maximum exposure under these arrangements is dependent on future claims that may be made against each Fund and, therefore, cannot be estimated; however, based on experience, the risk of loss from such claims is considered remote.

 

NOTE 9 – REDEMPTION FEES

 

Each Fund charges a 1.00% redemption fee on the redemption of Investor Class and Institutional Class shares held for 90 days or less. This fee (which is paid into the Fund) is imposed in order to help offset the transaction costs and administrative expenses associated with the activities of short-term “market timers” that engage in the frequent purchase and sale of Fund shares. The fee is accounted for as an addition to paid-in capital. Each Fund reserves the right to modify the terms of or terminate the fee at any time. There are limited exceptions to the imposition of the redemption fee. Please refer to Statements of Changes in Net Assets for fees recognized.

 

NOTE 10 – SUBSEQUENT EVENTS

 

In preparing these financial statements, the Funds have evaluated events and transactions for potential recognition or disclosure through the date the financial statements were available to be issued. The Funds have determined that there were no subsequent events that would need to be disclosed in the Funds’ financial statements.

 

22 

 

Zevenbergen Funds
Notes to the Financial Statements
December 31, 2020 (Unaudited)
 

 

NOTE 11 – COVID-19 RISK

 

The global outbreak of COVID-19 (commonly referred to as “coronavirus”) has disrupted economic markets and the prolonged economic impact is uncertain. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual issuers, are not known. The operational and financial performance of the issuers of securities in which the Funds invest depend on future developments, including the duration and spread of the outbreak, and such uncertainty may in turn adversely affect the value and liquidity of the Funds’ investments, impair the Funds’ ability to satisfy redemption requests, and negatively impact the Funds’ performance.

 

NOTE 12 – NEW ACCOUNTING PRONOUNCEMENT

 

In August 2018, FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). The primary focus of ASU 2018-13 is to improve the effectiveness of the disclosure requirements for fair value measurements. The changes affect all companies that are required to include fair value measurement disclosures. In general, the amendments in ASU 2018-13 are effective for all entities for fiscal years and interim periods within those fiscal years, beginning after December 15, 2019. The Funds have adopted all applicable provisions of ASU 2018-13.

 

23 

 

Zevenbergen Funds  
Expense Example  
December 31, 2020 (Unaudited)  
   

 

As a shareholder of the Funds, you incur two types of costs: (1) transaction costs, including redemption fees; and (2) ongoing costs, including management fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

 

The Example is based on an investment of $1,000 invested at the beginning of the six month period and held for the entire six month period from July 1, 2020 to December 31, 2020 (the “six month period”).

 

Actual Expenses

 

The “Actual Fund Return” lines in the table below provide information about actual account values and actual expenses. You may use the information in these lines, together with the amount you invested, to estimate the expenses you paid over the six month period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 equals 8.6), then multiply the result by the number in the corresponding line under the heading entitled “Expenses Paid During the Six Month Period” to estimate the expenses you paid on your account during the six month period.

 

Hypothetical Example for Comparison Purposes

 

The information in the table with the lines titled “Hypothetical 5% Return” provides information about hypothetical account values and hypothetical expenses based on the Funds’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Funds’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the six month period. You may use this information to compare the ongoing costs of investing in the Funds and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

 

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as redemption fees. Therefore, the information in the lines titled “Hypothetical 5% Return” is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if transactional costs were included, your costs would have been higher.

 

Expenses Paid During the Six Month Period

 

    Beginning
Account Value
  Ending
Account Value
  Annualized
Expense Ratio
  Expenses Paid
During the Six
Month Period (1)
                 
Growth Fund                
Investor Class                
Actual Fund Return   $1,000.00   $1,471.20   1.30%   $8.10
Hypothetical 5% Return   $1,000.00   $1,018.65   1.30%   $6.61
                 
Institutional Class                
Actual Fund Return   $1,000.00   $1,473.20   1.00%   $6.23
Hypothetical 5% Return   $1,000.00   $1,020.16   1.00%   $5.09
                 
Genea Fund                
Investor Class                
Actual Fund Return   $1,000.00   $1,630.60   1.40%   $9.28
Hypothetical 5% Return   $1,000.00   $1,018.15   1.40%   $7.12
                 
Institutional Class                
Actual Fund Return   $1,000.00   $1,633.00   1.10%   $7.30
Hypothetical 5% Return   $1,000.00   $1,019.66   1.10%   $5.60

(1) Expenses are equal to each of the Funds’ annualized expense ratio as indicated, multiplied by the average account value   over the six month period, multiplied by 184/366 (to reflect the “six month period”)

 

24 

 

 

 

Zevenbergen Funds

Additional Information

December 31, 2020 (Unaudited)

 

 

 

Form N-Q

 

The Funds file a complete schedule of portfolio holdings with the U.S. Securities and Exchange Commission (the “SEC”) for the first and third quarters of each fiscal year on Form N-Q or Part F of Form N-PORT (beginning with filings after March 31, 2020). The Funds’ Forms N-Q or Part F of Form N-PORT are available on the SEC’s website at www.sec.gov and may be reviewed and copied at the SEC’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1-800- SEC-0330.

 

Proxy Voting

 

You may obtain a description of the Funds’ proxy voting policy and voting records, without charge, upon request by contacting the Funds directly at 1-844-986-2746 or on the EDGAR Database on the SEC’s website at www.sec.gov. The Funds file their proxy voting records annually as of June 30, with the SEC on Form N-PX. The Funds’ Form N-PX is available without charge by visiting the SEC’s website at www.sec.gov and may be reviewed and copied at the SEC’s Public Reference Room in Washington D.C. You may obtain information on the operation of the Public Reference Room by calling 1-800-SEC-0330.

 

Approval of Investment Advisory Agreement (Unaudited)

 

Zevenbergen Growth Fund

 

At a meeting held on August 13 and 14, 2020, the Board of the Trust, including all Trustees who are not “interested persons” of the Trust (“Independent Trustees”), as that term is defined in the Investment Company Act of 1940, considered and approved the continuance of the investment advisory agreement (“Advisory Agreement”) with Zevenbergen Capital Investments LLC (the “Adviser”), for the Zevenbergen Growth Fund (the “Fund”).

 

Ahead of the August meeting, the Board received and reviewed substantial information regarding the Fund, the Adviser and the services provided by the Adviser to the Fund under the Advisory Agreement. This information formed the primary (but not exclusive) basis for the Board’s determinations. The information prepared specifically for the annual review of the Advisory Agreement supplemented the information provided to the Board and its committees throughout the year. The Board and its committees met regularly during the year and the information provided and topics discussed at such meetings were relevant to the review of the Advisory Agreement. Some of these reports and other data included, among other things, materials that outlined the investment performance of the Fund; compliance, regulatory, and risk management matters; the trading practices of the Adviser; valuation of investments; fund expenses; and overall market and regulatory developments. The Trustees considered the review of the Advisory Agreement to be an ongoing process and employed the accumulated information, knowledge, and experience they had gained during their tenure on the Board governing the Fund and working with the Adviser in their review of the Advisory Agreement. The Independent Trustees were advised by independent legal counsel during the annual review process as well as throughout the year, including meeting in executive sessions with such counsel without representatives from the Adviser present. In connection with their annual review, the Independent Trustees also received a memorandum from independent legal counsel outlining their fiduciary duties and legal standards in reviewing the Advisory Agreement.

 

In considering the continuance of the Advisory Agreement, the Board evaluated the following factors and made the following determinations. In its deliberations, the Board did not identify any single factor or piece of information as all important, controlling, or determinative of its decision, and each Trustee may have attributed different weights to the various factors and information.

 


In considering the nature, extent and quality of the services provided by the Adviser, the Trustees considered the Adviser’s specific responsibilities in all aspects of the day-to-day management of the Fund, as well as the qualifications, experience and responsibilities of the portfolio managers and other key personnel involved in the day-to-day activities of the Fund. The Board also considered the resources and compliance structure of the Adviser, including information regarding its compliance program, chief compliance officer, and compliance record and its disaster recovery/business continuity plan, including how the Adviser has operated through the COVID-19 pandemic. The Board also considered the existing relationship between the Adviser and the Trust, as well as the Board’s knowledge of the Adviser’s operations, and noted that during its February 2020 meeting it met with representatives of the Adviser to discuss Fund performance and investment outlook, as well as various marketing and compliance topics, including the Adviser’s risk management process. The Board concluded that the Adviser had sufficient quality and depth of personnel, resources, investment methods and compliance policies and procedures essential to performing its duties under the Advisory Agreement and that, in the Board’s view, the nature, overall quality, and extent of the management services provided were and would continue to be satisfactory and reliable.

 

25 

 

 

Zevenbergen Funds

Additional Information

December 31, 2020 (Unaudited)

 

 

 


In assessing the quality of the portfolio management delivered by the Adviser, the Board reviewed the performance of the Fund on both an absolute basis and in comparison to its peer group, relevant benchmark index, and a comparable composite of accounts managed by the Adviser. The Board considered that the Fund had significantly outperformed relative to its peer group median/average and its benchmark index for all periods as of June 30, 2020. The Board also considered that the Fund performed in-line with the Adviser’s composite performance for all periods as of June 30, 2020. The Board noted that the Fund had a performance record of nearly five years. The Board also considered the secular growth exposure of the Fund’s strategy and the long-term performance of the Adviser’s separately managed accounts.

 


The Trustees also reviewed the cost of the services, and the structure and level of advisory fee payable by the Fund, including a comparison of the fee to fees charged by a peer group of funds. The Board noted that the Adviser had contractually agreed to maintain an annual expense cap for each of the Fund’s classes. The Board noted that the Fund’s advisory fee was higher than, and the net expense ratio was slightly higher than, its peer group median/average. After reviewing the materials that were provided, the Trustees noted that the fee to be received by the Adviser was within the range of advisory fees charged to comparable funds and concluded that such fee was fair and reasonable.

 


The Trustees considered whether, based on the asset size of the Fund, economies of scale had been achieved. The Board also considered the Adviser’s commitment to maintain its caps on Fund expenses. The Trustees concluded that they will have the opportunity to periodically reexamine whether economies of scale have been achieved.

 


The Trustees considered the profitability of the Adviser from managing the Fund. In assessing the Adviser’s profitability, the Trustees reviewed the Adviser’s financial information that was provided in the materials and took into account both the direct and indirect benefits to the Adviser from managing the Fund. The Trustees concluded that the Adviser’s profits from managing the Fund were not excessive and, after a review of the relevant financial information, that the Adviser appeared to have adequate capitalization and/or would maintain adequate profit levels to support the Fund.

 

Zevenbergen Genea Fund

 

At a meeting held on August 13 and 14, 2020, the Board of the Trust, including all Trustees who are not “interested persons” of the Trust (“Independent Trustees”), as that term is defined in the Investment Company Act of 1940, considered and approved the continuance of the investment advisory agreement (“Advisory Agreement”) with Zevenbergen Capital Investments LLC (the “Adviser”), for the Zevenbergen Genea Fund (the “Fund”).

 

Ahead of the August meeting, the Board received and reviewed substantial information regarding the Fund, the Adviser and the services provided by the Adviser to the Fund under the Advisory Agreement. This information formed the primary (but not exclusive) basis for the Board’s determinations. The information prepared specifically for the annual review of the Advisory Agreement supplemented the information provided to the Board and its committees throughout the year. The Board and its committees met regularly during the year and the information provided and topics discussed at such meetings were relevant to the review of the Advisory Agreement. Some of these reports and other data included, among other things, materials that outlined the investment performance of the Fund; compliance, regulatory, and risk management matters; the trading practices of the Adviser; valuation of investments; fund expenses; and overall market and regulatory developments. The Trustees considered the review of the Advisory Agreement to be an ongoing process and employed the accumulated information, knowledge, and experience they had gained during their tenure on the Board governing the Fund and working with the Adviser in their review of the Advisory Agreement. The Independent Trustees were advised by independent legal counsel during the annual review process as well as throughout the year, including meeting in executive sessions with such counsel without representatives from the Adviser present. In connection with their annual review, the Independent Trustees also received a memorandum from independent legal counsel outlining their fiduciary duties and legal standards in reviewing the Advisory Agreement.

 

26 

 

 

Zevenbergen Funds

Additional Information

December 31, 2020 (Unaudited)

 

 

 

In considering the continuance of the Advisory Agreement, the Board evaluated the following factors and made the following determinations. In its deliberations, the Board did not identify any single factor or piece of information as all important, controlling, or determinative of its decision, and each Trustee may have attributed different weights to the various factors and information.

 


In considering the nature, extent and quality of the services provided by the Adviser, the Trustees considered the Adviser’s specific responsibilities in all aspects of the day-to-day management of the Fund, as well as the qualifications, experience and responsibilities of the portfolio managers and other key personnel who are involved in the day-to-day activities of the Fund. The Board also considered the Adviser’s resources and compliance structure, including information regarding its compliance program, chief compliance officer, and compliance record, and its disaster recovery/business continuity plan, including how the Adviser has operated through the COVID-19 pandemic. The Board also considered the existing relationship between the Adviser and the Trust, as well as the Board’s knowledge of the Adviser’s operations, and noted that during its February 2020 meeting it met with representatives of the Adviser to discuss Fund performance and investment outlook, as well as various marketing and compliance topics, including the Adviser’s risk management process. The Board concluded that the Adviser had sufficient quality and depth of personnel, resources, investment methods and compliance policies and procedures essential to performing its duties under the Advisory Agreement and that, in the Board’s view, the nature, overall quality, and extent of the management services provided were and would continue to be satisfactory and reliable.

 


In assessing the quality of the portfolio management delivered by the Adviser, the Board reviewed the performance of the Fund on both an absolute basis and in comparison to its peer group, relevant benchmark index, and a comparable composite of accounts managed by the Adviser. The Board considered that the Fund had significantly outperformed relative to its peer group average/median and its benchmark index for all periods as of June 30, 2020, and that its performance was slightly lower than the Adviser’s composite performance for all periods as of June 30, 2020. The Board noted that the Fund had a performance record of nearly five years. The Board also considered the secular growth exposure of the Fund’s strategy and the long-term performance of the Adviser’s separately managed accounts.

 


The Trustees also reviewed the cost of the services, and the structure and level of advisory fees payable by the Fund, including a comparison of the fee to fees payable by a peer group of funds. The Board noted that the Adviser had contractually agreed to maintain an annual expense cap for each of the Fund’s classes. The Board noted that the Fund’s advisory fee and net expense ratio were higher than its peer group median/average, but were within the peer group range. After reviewing the materials that were provided, the Trustees concluded that the fee to be received by the Adviser was fair and reasonable.

 


The Trustees considered whether, based on the asset size of the Fund, economies of scale had been achieved. The Board also considered the Adviser’s commitment to maintain its caps on Fund expenses. The Trustees concluded that they will have the opportunity to periodically reexamine whether economies of scale have been achieved.

 


The Trustees considered the profitability of the Adviser from managing the Fund. In assessing the Adviser’s profitability, the Trustees reviewed the Adviser’s financial information that was provided in the materials and took into account both the direct and indirect benefits to The Adviser from managing the Fund. The Trustees concluded that the Adviser’s profits from managing the Fund were not excessive and, after a review of the relevant financial information, that the Adviser appeared to have adequate capitalization and/or would maintain adequate profit levels to support the Fund.

 

27 

 

 

PRIVACY NOTICE

 

The Funds collect non-public information about you from the following sources:

 


Information we receive about you on applications or other forms;

 


Information you give us orally; and/or

 


Information about your transactions with us or others.

  

We do not disclose any non-public personal information about our customers or former customers without the customer’s authorization, except as permitted by law or in response to inquiries from governmental authorities. We may share information with affiliated and unaffiliated third parties with whom we have contracts for servicing the Funds. We will provide unaffiliated third parties with only the information necessary to carry out their assigned responsibilities. We maintain physical, electronic and procedural safeguards to guard your non-public personal information and require third parties to treat your personal information with the same high degree of confidentiality.

 

In the event that you hold shares of the Funds through a financial intermediary, including, but not limited to, a broker-dealer, bank, or trust company, the privacy policy of your financial intermediary would govern how your non-public personal information would be shared by those entities with unaffiliated third parties.

 

28 

 

Investment Adviser

Zevenbergen Capital Investments LLC

601 Union Street, Suite 4600

Seattle, Washington 98101

 

Distributor

Quasar Distributors, LLC

111 East Kilbourn Ave. Suite 2200

Milwaukee, Wisconsin 53202

 

Custodian

U.S. Bank National Association

Custody Operations

1555 North River Center Drive, Suite 302

Milwaukee, Wisconsin 53212

 

Transfer Agent, Fund Accountant and Fund Administrator

U.S. Bancorp Fund Services, LLC

615 East Michigan Street

Milwaukee, Wisconsin 53202

 

Independent Registered Public Accounting Firm

BBD, LLP

1835 Market Street, 3rd Floor

Philadelphia, Pennsylvania 19103

 

Legal Counsel

Morgan, Lewis & Bockius LLP

1111 Pennsylvania Avenue, NW

Washington, DC 20004

 

This report has been prepared for shareholders and may be distributed to others only if preceded or accompanied by a current prospectus.

 



(b)
Not applicable for this Registrant.



Item 2. Code of Ethics.

Not applicable for semi-annual reports

Item 3. Audit Committee Financial Expert.

Not applicable for semi-annual reports

Item 4. Principal Accountant Fees and Services.

Not applicable for semi-annual reports

Item 5. Audit Committee of Listed Registrants.

Not applicable to registrants who are not listed issuers (as defined in Rule 10A-3 under the Securities Exchange Act of 1934).

Item 6. Investments.

Schedule of Investments is included as part of the report to shareholders filed under Item 1 of this Form.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

Item 9. Purchases of Equity Securities by Closed‑End Management Investment Company and Affiliated Purchasers.

Not applicable to open-end investment companies.

Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of trustees.



Item 11. Controls and Procedures.

(a)
The Registrant’s President and Treasurer have reviewed the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d‑15(b) under the Securities Exchange Act of 1934.  Based on their review, such officers have concluded that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the Registrant and by the Registrant’s service provider.

(b)
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies

Not applicable to open-end investment companies.

Item 13. Exhibits.

(a)
(1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit. Not applicable for semi-annual reports.


(3) Any written solicitation to purchase securities under Rule 23c‑1 under the Act sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons.  Not applicable to open-end investment companies.

(4) Change in the registrant’s independent public accountant.  There was no change in the registrant’s independent public accountant for the period covered by this report.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Trust for Advised Portfolios                                        


By /s/ Christopher E. Kashmerick                                
                  Christopher E. Kashmerick, President

Date March 10, 2021                                                    


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By /s/ Christopher E. Kashmerick                               
                  Christopher E. Kashmerick, President

Date March 10, 2021                                                   


By /s/ Russell B. Simon                                               
                  Russell B. Simon, Treasurer

Date March 10, 2021